News
14hon MSN
In India, access to ways of managing obesity is not universally available to most patients, Dr Prabhakaran Dorairaj, ...
2d
MedPage Today on MSNSotagliflozin Offers Benefits in Type 2 Diabetes With Reduced Kidney FunctionSince SGLT2 inhibitors primarily work on the renal component as its mechanism of action, by flushing sugar out through the ...
6d
News-Medical.Net on MSNTirzepatide outperforms semaglutide for weight loss in people without diabetesA head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...
2d
ScienceAlert on MSNUltra-Processed Foods Linked to Early Signs of Parkinson's DiseaseUltra-processed foods are associated with a rogues' gallery of health problems, including elevated risk for obesity, dementia ...
In the first direct comparison study involving individuals with obesity, tirzepatide demonstrated approximately 50% greater ...
Over the past few years, a new class of injectable medications has changed the way obesity is treated. Two drugs—tirzepatide and semaglutide—have shown striking results in helping people lose weight ...
High cardiovascular health was associated with a reduced effect of insulin resistance on all-cause and cardiovascular mortality risk.
Metformin use in patients with HIV and type 2 diabetes who had at least 2 years of exposure to effective ART showed no significant effect on immune reconstitution.
What do we know about the ways major depressive disorder can affect comorbidities, and how does it affect treatment regimens?
Spending too much time sitting or lying down can fuel dementia risk, heart problems, and can even increase the risk of cancer ...
List View Card View not selected Table View not selected ...
Men with gout and obesity receiving febuxostat-based ULT were less likely to achieve SU targets and more frequently experienced disease flares.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results